A Randomized Double Blind Placebo Controlled Clinical Evaluation Of Extract Of Andrographis Paniculata (KalmCold) In Patients With Uncomplicated Upper Respiratory Tract Infection

Effect Decrease
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 223
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Overweight, Average
Notes for this study:
200mg of Andrographis extract (31% Andrographolide) in two divided doses of 100mg for 5 days was significantly better than placebo at reducing signs of upper respiratory tract infection